After a successful first five years, a statewide cancer research consortium has been awarded a six-year grant expected to result in more than $11 million in funding from the National Cancer Institute (NCI) to enroll even more Georgians in important clinical trials.
The Georgia NCI Community Oncology Research Program (NCORP) is a collaboration between the two largest community oncology clinical trial programs in Georgia: Northside Hospital Cancer Institute in Atlanta and the Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph’s/Candler in Savannah, and the Georgia Center for Oncology Research and Education (Georgia CORE) in Atlanta.
Four additional key cancer programs and Georgia CORE research network affiliates were selected to participate in the Georgia NCORP partnership based on their leadership and track record in community-based oncology research: John B. Amos Cancer Center in Columbus; Harbin Clinic in Rome; Peyton Anderson Cancer Center, Navicent Health in Macon; and Cancer Services at Northeast Georgia Medical Center in Gainesville.
NCORP began in 2014 to conduct multi-site cancer clinical trials and cancer delivery studies in their communities. From 2014-2018, approximately 30,000 patients nationwide were enrolled in NCI clinical trials through the NCORP sites.
The Georgia NCORP partnership is one of only 32 Community Sites selected to receive cancer research funding from the NCI for the next six years. Since 2014, Georgia NCORP has enrolled 2,530 cancer patients in clinical trials. It is one of only 10 NCORP networks to receive ‘High Performance” status from the NCI.
“The National Cancer Institute created NCORP as a comprehensive community and academic initiative to provide access to cancer trials, including cutting edge treatment trials, precision medicine, symptom control, cancer prevention, as well as cancer care delivery research, to individuals in their own local communities,” said Northside Hospital Cancer Institute’s Dr. Guilherme Cantuaria, who has served as the principal investigator for this partnership since its inception in 2014. “These studies will have great potential for improving cancer outcomes and reducing disparities in care. We are especially proud that the NCI selection team evaluated the Georgia NCORP capabilities as outstanding.”
“The Georgia NCORP team was one of the most effective groups in the nation at enrolling patients into national clinical trials,” said H.A. Zaren, co-principal investigator for the partnership and medical director at the Nancy N. and J.C. Lewis Cancer & Research Pavilion at St. Joseph’s/Candler. “It demonstrates the dedication that the entire team has toward improving cancer outcomes and the optimism that people in Georgia and the nation will have even better treatments to fight cancer. This second grant will help many people, especially minority patients and the medically underserved.”
Georgia NCORP provides Georgians with access to state-of-the-art cancer prevention, screening, control, treatment and post-treatment trials within their own communities. There are more than 100 oncology clinical providers in 41 different locations throughout the state, as well as the clinical trial leadership and research services of Georgia CORE.
“GA NCORP is a unique collaboration that has enhanced the quality of cancer care in Georgia by expanding access to clinical trials,” said Nancy M. Paris, president and CEO of Georgia CORE, which is a non-profit leader in improving the quality of cancer care through clinical research and education. “With new NCI funding we will build on the strengths of committed doctors and cancer centers to deliver research and personalized treatments to those most vulnerable — rural, racial, and ethnic minorities; children and the elderly. Georgia CORE is honored to be a partner in this exemplary statewide effort.”
Patients with cancer or increased risks of cancer in Georgia will have access to NCI-funded clinical trials through their cancer physicians at a participating NCORP network site. Through the NCORP network, community physicians will be able to collaborate with the NCI Clinical Trials Network Research Bases (NCTN) and Lead Academic Participating Sites (LAPS) on the development of research studies that impact patients in their communities.
For more information about Georgia NCORP, visit: gancorp.org.